Nucleotide Metabolism Flashcards
(35 cards)
nucleoSIDE
ribose ring + nitrogenous base at 1’
nucleoTIDE
nucleoside + phosphate esterified at 5’
deoxyribonucledotides
have H instead of OH at 2’ of ribose ring
pyrimidine
one ring w/ 2 nitrogens
cut of py
purine
two ring structure each w/ 2 N’s
pur as gold
roles of nucleotides
- energy metabolism (ATP, GTP)
- nucleic acids (NTPs and dNTPs)
- coenzymes (NAD, FAD, coA)
- activated intermediates (UDP-glucose, GDP-mannose, SAM)
- allosteric modulators (AMP, ATP, cAMP, cGMP)
- physiological modulators (ADP, adenosine)
salvage pathways
what it do
allow generation of nucleotides from free bases and nucleosides from diet
since de novo synthesis energetically expensive
de novo synthesis
purines-basic
ring strucutre assembled on a base (PRPP)
de novo synthesis
purine pathway
- assemble PRPP, start w/ ribose-5-phosphate from PPP, w/ PRPP synthetase
- committed step, convert to PRA using glutamine
- make IMP w/ carbons and nitrogens from amino acids, carbon and oxygen from HCO3-, carbon from N10formyl THF, ATP hydrolysis
- convert IMP to AMP or GMP
- convert to ATP and GTP w/ NMPs aka adenylate kinase or guanylate kinase
GTP and ATP are readily interconverted
regulation of purine synthesis
- PRPP synthetase, feedback inhibition by ADP and GDP
- commited step (amidophosphoribosyltransferase) aka PRA by allosteric effectors
-inhibitors: AMP and GMP bc end prodcuts
-activators: PRPP
ADP and GDP are the purine nucleotides
purine degradation
GMP
@ liver
1. GMP to guanosine via 5’nucleotidase removing P
2. convert to free base (guanine) via purine nucleoside phosphorylase removing ribose
GMP>guanosine>guanine
purine degradation
AMP
route 1:
1. AMP to adenosine via 5’-nucleotidase remove P
2. convert to inosine via adenosine deaminase
3. convert to free base hypoxanthine via pruine nucleoside phosphorylase removing ribose
route 2:
1. AMP to IMP via AMP deaminase
2. IMP to inosine via 5’-nucleotidase dephosphorylating
3. convert to hypoxanthine via purine nucleoside phosphorylase
adenosine deaminase = lymphocytes
AMP deaminase = muscle
purine degradation
final steps
- hypoxanthine and guanine converted to xanthine
- xanthine oxidase converts it to uric acid
- excreted via kidneys
hyperuricemia
excess uric acid in blood
from reduced excretion (renal insufficiency, metabolic acidosis)
OR
inc production (inc nucleotide turnover aka sickle cell, G6DP deficiency, chemo, or purine rich diet)
alcohol does both
treat w/ allopurinol
gout
crystals of sodium urate deposit in joints of extremities (esp first toe)
bc uric acid is relatively insoluble and close to limit of solubility normally
treat with allopurinol
kidney stones
high concentrations of uric acid in urine lead to deposition of stones in kidney aka urolithiasis
10-25% ppl with gout also have stones
allopurinol
effective treatment for hyperuricemia
metabolizes to oxypurinol that competitively inhibits xanthine oxidase
=more hypoxanthine and xanthine that are more soluble than uric acid so excreted easier
de novo synthesis
pyrimidines-basic
start as synthesis of free bases then get transferred to ribose
synthesis of UMP
first pyrimidine made
- syn carbamoyl phosphate w/ glutamine + bicarb
- carbamoyl aspartate by adding aspartate
- cyclization = dihydroorotate
- dehydrogenation = orotate
- syn OMP w/ PRPP
- decarboxylate = UMP
CAD
single multifunctional protein w/ 3 distinct active sites for steps 1/2/3 of pryrimidine syn
Carbamoyl phosphate synthetase II
Aspartate transcarbamoylase
Dihydroorotase
UMP synthase
single multifunctional protein for last two steps of pyrimidine syn
orotate phosphoribosyltransferase
OMP decarboxylase
orotic aciduria
defect in UMP synthase so orotic acid accumlates in urine
symptoms of megaloblastic anemia and maybe cellular immunity
treat w/ pyrimidine supplement (uridine)
synthesis of CMP
- UMP to UTP w/NMP
- UTP to CTP w/CTP synthase and glutamine
regulation of pryimidine
- carbamoyl phosphate synthetase II
-inhibited by UTP
-activated by PRPP - CTP synthase
-inhibited by CTP
-activated by UTP